Kenalog-40 is an injectable corticosteroid used to treat a wide range of inflammatory and immune-related conditions, from severe allergies and joint pain to skin diseases and autoimmune disorders. The “40” refers to its concentration: 40 milligrams of the active ingredient, triamcinolone acetonide, per milliliter. It works by powerfully suppressing inflammation and calming an overactive immune system, and its effects can last several weeks from a single injection.
How Kenalog-40 Works
Triamcinolone acetonide, the drug inside Kenalog-40, is a synthetic corticosteroid. It reduces inflammation through several pathways at once. It blocks the release of chemicals your body uses to trigger swelling, redness, and pain. It also prevents immune cells from migrating to the site of inflammation, which is why it’s effective for both localized problems like a swollen joint and widespread conditions like severe allergic reactions.
Because Kenalog-40 is a suspension (tiny particles suspended in liquid rather than fully dissolved), it acts as a slow-release depot in whatever tissue it’s injected into. This extended-release property is what gives it a therapeutic effect lasting several weeks, unlike oral steroids that clear the body within hours.
Joint and Musculoskeletal Conditions
One of the most common reasons people receive Kenalog-40 is for joint inflammation. It’s approved for use in rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and acute gouty arthritis. A survey of rheumatologists found that 40 mg of triamcinolone is the most commonly used dose for joint, bursa, and tendon sheath injections across a range of conditions including osteoarthritis.
The dose depends on joint size. Smaller joints like those in the fingers or wrist typically receive 2.5 to 5 mg, while larger joints like the knee or shoulder may receive 5 to 15 mg. For broader soft tissue areas, doses up to 40 mg are common. A single injection into one joint is often enough to provide relief, though some people need repeat injections. When multiple joints are treated in the same session, the combined dose can go up to 80 mg total.
There is one important caveat for knee osteoarthritis specifically. A study published in BMC Musculoskeletal Disorders found that a 10 mg dose provided pain relief that was not inferior to the standard 40 mg dose, and researchers noted that repeated 40 mg injections every three months for two years was associated with greater cartilage volume loss compared to placebo injections. For people with osteoarthritis who may need ongoing treatment, a lower dose may offer a better balance of benefit and joint safety.
Severe Allergic Conditions
Kenalog-40 is approved for allergic conditions that haven’t responded adequately to standard treatments like antihistamines or nasal sprays. These include severe seasonal or year-round allergic rhinitis, asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, and serum sickness. It’s generally reserved for situations where oral corticosteroids aren’t practical or when a patient needs sustained relief without the burden of taking daily pills.
Skin Diseases
For systemic (intramuscular) use, Kenalog-40 is approved for serious skin conditions including pemphigus, severe erythema multiforme, and certain types of dermatitis that affect large areas of skin.
Kenalog-40 also sees significant use as an intralesional injection, meaning it’s injected directly into a specific skin lesion. Keloid scars are one of the most well-studied applications. Doctors inject the medication directly into the dense scar tissue to flatten and soften it. The concentration used varies depending on the location and size of the keloid: trunk and extremity keloids often start at the full 40 mg/mL concentration, while smaller or more sensitive areas may use a diluted 10 mg/mL concentration. Most keloids require a median of about two injection sessions, spaced three to eight weeks apart, though some need up to five or six sessions. Injecting keloids is physically challenging because the scar tissue is extremely dense, requiring significant pressure on the syringe.
Autoimmune and Blood Disorders
Kenalog-40 is used in several autoimmune conditions where the immune system attacks the body’s own tissues. These include systemic lupus erythematosus, dermatomyositis, polymyositis, and autoimmune hemolytic anemia (where the body destroys its own red blood cells). It’s also indicated for certain blood disorders like Diamond-Blackfan anemia and selected cases of low platelet counts.
For multiple sclerosis, Kenalog-40 is approved specifically for acute flare-ups, not as a long-term disease management strategy. It can also be used for brain swelling associated with tumors.
Other Approved Uses
The full list of approved conditions is broader than most people expect. Kenalog-40 is also indicated for:
- Endocrine disorders: adrenal insufficiency (as a supplemental therapy), congenital adrenal hyperplasia, and high calcium levels caused by cancer
- Gastrointestinal diseases: Crohn’s disease and ulcerative colitis during critical flare-ups
- Respiratory diseases: sarcoidosis, berylliosis, and certain types of pneumonia caused by overactive immune cells
- Eye conditions: uveitis, temporal arteritis, and other inflammatory eye diseases that haven’t responded to steroid eye drops
- Kidney disease: nephrotic syndrome, to reduce protein loss in the urine
- Cancer: palliative management of leukemias and lymphomas
How Long the Effects Last
Kenalog-40 has an extended duration of action that can be sustained over several weeks. Studies measuring the body’s cortisol production (which gets temporarily suppressed by any corticosteroid) show that after a single intramuscular dose, suppression begins within 24 to 48 hours and gradually returns to normal over 30 to 40 days. This timeline closely mirrors how long the therapeutic effects last, meaning you can expect relief for roughly four to six weeks from a single injection.
Side Effects and Risks
Because Kenalog-40 is a potent corticosteroid, it carries the same general risks as other steroids in this class. Local side effects at the injection site can include skin thinning (atrophy), lightening of skin color, and tissue dimpling, particularly with intralesional or shallow injections. For joint injections, there’s a small risk of infection and temporary increased pain in the first day or two.
Systemically, the main concern with repeated use is suppression of your body’s natural cortisol production. After a single dose, your adrenal glands may take 30 to 40 days to fully resume normal function. During this window, your body is less equipped to handle physical stress like illness or injury. Other possible systemic effects include elevated blood sugar, fluid retention, mood changes, and difficulty sleeping.
Blood Sugar Spikes in People With Diabetes
If you have diabetes, a steroid injection will temporarily raise your blood sugar. Research measuring glucose levels after musculoskeletal steroid injections found that blood sugar increased by an average of 64 mg/dL on the first day after injection. By the second day, levels had returned to baseline for most people. The spike was more pronounced in people with poorly controlled diabetes: those with an HbA1c above 7% saw an average increase of about 99 mg/dL, compared to about 48 mg/dL for those with better control. People using insulin experienced the largest spikes, averaging around 135 mg/dL above baseline. The dose and injection site did not significantly affect how much blood sugar rose.
Who Should Not Get Kenalog-40
Kenalog-40 is contraindicated in people with systemic fungal infections because corticosteroids suppress the immune defenses needed to fight fungi, potentially allowing the infection to spread. It’s also contraindicated for idiopathic thrombocytopenic purpura (a bleeding disorder caused by low platelets) when given intramuscularly, since the injection itself can cause bleeding into the muscle. Anyone with a known allergy to any component of the formulation should also avoid it.